Patents are litigated in the biopharmaceutical industry perhaps more often than any other form of IP
Gary N. Frischling, J.D.
Advertisement
Articles by Gary N. Frischling, J.D.
Advertisement
Latest Updated Articles
Intellectual Property LitigationPublished: August 10th 2005 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Report - Digital Transformation in Biopharma: The Gap Between Hype and Implementation
2
Reducing CAR-T Manufacturing Times and Cost: Q&A with Trenchant’s Jon Ellis
3
How Big Biopharma Investment in CGTs Will Redefine the Industry Pipeline
4
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
5
